Commentary 10.1172/JCI144685
Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, California, USA.
Address correspondence to: Andrew Flyak, Division of Biology and Biological Engineering, California, Institute of Technology, Pasadena, California, 91125, USA. Phone: 626.395.8351; Email: flyaka@caltech.edu.
Find articles by
Flyak, A.
in:
JCI
|
PubMed
|
Google Scholar
|
Published November 20, 2020 - More info
Many individuals possess B cells capable of recognizing epitopes on the spike glycoprotein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In this issue of the JCI, Paschold and Simnica et al. interrogated the frequency of SARS-CoV-2–specific B cell receptor rearrangements in healthy subjects based on age and cancer status. The authors found that while SARS-CoV-2–specific antibody signatures can be identified in the repertoires of young, healthy individuals, such sequences are less frequent in elderly subjects or patients with cancer. Overall, this study sheds light on B cell repertoire restrictions that might lead to an unfavorable clinical course of coronavirus disease 2019 infection in at-risk populations.
A subscription is required for you to read this article in full. If you are a subscriber, you may sign in to continue reading.
Click here to sign into your account.
Please select one of the subscription options, which includes a low-cost option just for this article.
If you are at an institution or library and believe you should have access, please check with your librarian or administrator (more information).
Please try these troubleshooting tips.